Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h
p38 mitogen-activated protein kinase up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages
✍ Scribed by Hee J. Kim; Hui S. Lee; Young H. Chong; Jihee Lee Kang
- Book ID
- 108287321
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 388 KB
- Volume
- 225
- Category
- Article
- ISSN
- 0300-483X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Glucosamine supplements are very promising nonsteroidal anti‐inflammatory agents widely used for the treatment of arthritis in animals and humans. In this study, we have proposed the molecular mechanism underlying the anti‐inflammatory properties of glucosamine hydrochloride (GLN) using
## Abstract Dioscorealide B (DB), a naphthofuranoxepin has been purified from an ethanolic extract of the rhizome of __Dioscorea membranacea__ Pierre ex Prain & Burkill which has been used to treat inflammation and cancer in Thai Traditional Medicine. Previously, DB has been reported to have anti‐i
## Abstract Blood vessel injury results in limited oxygen tension and diffusion leading to hypoxia, increased anaerobic metabolism, and elevated production of acidic metabolites that cannot be easily removed due to the reduced blood flow. Therefore, an acidic extracellular pH occurs in the local mi